SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is currently trending as investors monitor its resilience amid macroeconomic volatility and ongoing debates surrounding the impact of potential tariff refunds on retail pricing. The community remains focused on Costco's defensive strengths, with frequent discussions centered on its robust membership renewal rates, traffic growth, and valuation relative to the broader consumer staples sector.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is generating significant investor interest driven by high trading volumes, active momentum in its clinical-stage pipeline, and multiple analyst endorsements from firms like Guggenheim and HC Wainwright. Community discussion is focused on the high-stakes Phase 2 LOTUS trial readout expected in 2026 and ongoing debates regarding the company's financial risk profile versus the potential upside of its immunology platform.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point for the community due to renewed institutional interest, shifting ecosystem management, and ongoing discussions regarding its quantum-resistant technology. While some traders debate the asset's long-term viability following historic price volatility, active participants are heavily focused on potential regulatory catalysts and the ongoing expansion of its real-world asset (RWA) utility.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF is capturing investor attention as they rotate toward defensive, value-oriented positions amidst broader market volatility. The community is actively debating the fund's resilience, with many investors maintaining a long-term 'buy and hold' strategy despite recent stagnant performance, while others monitor the ETF's sector diversification and dividend growth potential as a reliable hedge.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community speculates on a major upcoming partnership announcement, with many pointing to a connection with Stellar or a potential collaboration with Ripple/XRP at an upcoming industry event. Investors are actively debating the project's long-term utility in global payroll and real-world adoption, balancing high-conviction sentiment against skepticism regarding its price performance and market volatility.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is currently trending due to intense volatility following a quarterly earnings report that featured a strong double beat on top and bottom lines but provided cautious forward revenue guidance. The community is actively debating whether the double-digit price decline is a baseless overreaction caused by market makers or a justified correction given the stock's high valuation and competitive concerns within the AI infrastructure sector.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors weigh the potential impact of looming pharmaceutical tariffs, which are pushing the company to increase its U.S. manufacturing footprint. Simultaneously, the community is actively debating the company's aggressive M&A strategy, particularly its focus on expanding oncology and T-cell engager therapy pipelines, while keeping a watchful eye on patent litigation risks.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as the community debates its long-term viability, with supporters pointing to upcoming regulatory clarity like the Clarity Act and existing infrastructure partnerships, while skeptics emphasize a prolonged downward price trend and lack of active communication from project leadership.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is a primary focal point of market discourse following the FDA approval of Foundayo, its once-daily oral GLP-1 weight-loss pill, which analysts view as a major step toward expanding the obesity treatment market through improved convenience and scalability. While community discussion remains intense regarding its competitive positioning against Novo Nordisks oral offerings, the broader pharma sector is also digesting the implications of potential new pharmaceutical tariff policies and ongoing M&A activity, keeping Eli Lillys valuation and long-term growth trajectory at the center of investor focus.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is seeing significant market activity and heightened community discourse driven by persistent acquisition rumors and notable institutional volume in after-hours trading. Traders are actively debating the stock's valuation relative to its rare disease pipeline, while observing unconventional trading patterns that have fueled speculation of a potential buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Loren Robert D Buys 81,466 Shares of Xcel Brands (NASDAQ:XELB) Stock

Xcel Brands, Inc (NASDAQ:XELB - Get Free Report) CEO Loren Robert D purchased 81,466 shares of Xcel Brands stock in a transaction that occurred on Wednesday, December 17th. The stock was bought at an...

Xcel Brands (NASDAQ:XELB) CEO Buys $17,500.00 in Stock

Xcel Brands, Inc (NASDAQ:XELB - Get Free Report) CEO Loren Robert D bought 50,000 shares of Xcel Brands stock in a transaction that occurred on Friday, December 5th. The shares were acquired at an...

XCel Brands (XELB) Reports Q3 Loss, Misses Revenue Estimates

XCel Brands (XELB) delivered earnings and revenue surprises of -117.20% and -27.87%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Xcel Brands (XELB) Q3 2025 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Shares of Xcel Brands surged nearly 70% in after-hours trading on Friday after the company disclosed a major settlement agreement resolving disputes related to its stake in the Isaac Mizrahi brand.A filing with the SEC on Thursday showed that Xcel Brands entered into a settlement agreement with IM Topco, IMWHP, and IMWHP2 — affiliates of brand management firm WHP Global that control the Isaac Mizrahi brand.Under the agreement, Xcel will transfer its 17.5% equity interest in IM Topco to IMWHP2 on Oct. 1, effectively exiting its ownership position.As part of the settlement, Xcel received a capital appreciation right entitling it to 15% of the net consideration received by IM Topco, IMWHP, IMWHP2, and other equity holders in excess of $46 million from any qualifying capital transaction involving IM Topco through Sept. 1, 2032. The filing clarified that this right would be payable within 10 business days of any such transaction’s closing.The agreement also releases Xcel-CT MFG, a unit of Xcel Brands, from any future liability under certain provisions of a prior License Termination Agreement between IM Topco and Xcel-CT.As part of the settlement terms, Xcel executives Joe Falco and Ken Downing will continue providing services to IM Topco through&nbsp;Dec. 31, with compensation of $33,333 per month. IM Topco may choose to retain Falco’s services on a month-to-month basis through 2026 at a rate of $12,500 per month.The filing further noted that Xcel Brands, Xcel-CT, and IM Brands will continue to provide support to IM Topco’s team through workspace access and operational assistance until the end of 2025.On Stocktwits, retail sentiment for Xcel Brands was ‘extremely bullish’ amid ‘extremely high’ message volume.One retail trader noted that short sellers appeared to be under mounting pressure,&nbsp;citing&nbsp;a rise in short interest to 14.3% of the float and suggesting that a sharp squeeze could be imminent if momentum persists.&nbsp;<stembedurl>https://stocktwits.com/S2K_TP/message/630867701</stembedurl>Another user predicted the stock could climb further to $10 on Friday.<stembedurl>https://stocktwits.com/Aburose/message/630870098</stembedurl><a href="https://stocktwits.com/symbol/XELB">Xcel Brands stock</a> has declined 66% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Isaac Mizrahi (L) and Robert D'Loren attend Xcel Brands, Inc. rings The NASDAQ Closing Bell at NASDAQ MarketSite on September 2, 2015 in New York City. (Photo by Rob Kim/Getty Images)

Why Xcel Brands Stock Surged 70% After-Hours Today

The company announced a settlement involving its exit from IM Topco, the owner of the Isaac Mizrahi brand, as part of a deal with WHP Global affiliates IMWHP and IMWHP2.

Equity

XCel Brands (XELB) Reports Q2 Loss, Misses Revenue Estimates

XCel Brands (XELB) delivered earnings and revenue surprises of +26.00% and -28.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

On Holding (ONON) Reports Q2 Loss, Beats Revenue Estimates

On Holding (ONON) delivered earnings and revenue surprises of -145.83% and +6.69%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Tapestry (TPR) Earnings Expected to Grow: Should You Buy?

Tapestry (TPR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate XCel Brands (XELB) to Report a Decline in Earnings: What to Look Out for

XCel Brands (XELB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tilly's (TLYS) Reports Q1 Loss, Lags Revenue Estimates

XCel Brands, Inc. engages in the design, production, marketing, wholesale, and direct-to-consumer sales of branded apparel, footwear, accessories, jewelry, home goods and other consumer products. It owns and manages Isaac Mizrahi, Judith Ripka, Halston, C Wonder, Longaberger, and Lori Goldstein brands. The company was founded by Robert W. D'Loren on August 31, 1989 and is headquartered in New York, NY.

Xcel Brands Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

XELB
Xcel Brands Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest XELB News

XELBXcel Brands Inc